Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

Showing 41-50 of 3906

23 Jun 2021  |  Global

Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

USD 4,950.00
23 Jun 2021  |  Global

Global RNA Therapeutics:Technology Growth Opportunities

Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics

RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...

USD 4,950.00

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations focused on stem cell therapy -- both allogeneic and autologous. A number of emerging technologies have been discussed for a variety of therapeutic indications including cancer, autoimmune diseases, and neurological disorders. Further, innovat...

USD 950.00
17 Jun 2021  |  North America

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

USD 4,950.00
14 Jun 2021  |  North America

Growth Opportunities for MedTech in the Transformation of the US Healthcare Provider Ecosystem

Transformational Growth in the Care Delivery Landscape is Changing Health Systems into Systems of Health

Healthcare providers are on the verge of reinventing their role in the care delivery process due to various external factors, such as the following: • Unsustainable growth in healthcare spending driving continuous downward pressure and declining operating margins • The emergence of alternative payment models that focus on patient outcome an...

USD 4,950.00
01 Jun 2021  |  North America

Frost Radar™: US Population Health Management Market, 2021

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...

USD 4,950.00

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations in this issue cover various AI enabled diagnostic and screening solutions. The issue also profiles various advanced point-of-care diagnostics and emerging chronic diseas...

USD 950.00

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) discusses antisense oligonucleotides-based therapy for treating cystic fibrosis, novel therapeutics for loculated pleural effusion, medicinal food to maintain lung health, and developing novel therapeutics with modified thioredoxin. The TOE also focuses on devel...

USD 950.00
21 May 2021  |  North America

Explosion of Data Drives the US Social Determinants of Health Market

Proven Returns on Investment will Ignite Transformational Growth

This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...

USD 2,450.00
13 May 2021  |  Global

Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market

Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...

USD 4,950.00

Showing 41-50 of 3906